Found: 229
Select item for more details and to access through your institution.
B cells as drug factories.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 6, p. 823, doi. 10.1038/s41587-024-02283-3
- By:
- Publication type:
- Article
A second chance for plant biotechnology in Europe.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 5, p. 687, doi. 10.1038/s41587-024-02246-8
- By:
- Publication type:
- Article
Innovators want pills to treat sickle cell disease. Can they match gene therapy?
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 347, doi. 10.1038/s41587-024-02179-2
- By:
- Publication type:
- Article
Can single-cell biology realize the promise of precision medicine?
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 2, p. 159, doi. 10.1038/s41587-024-02138-x
- By:
- Publication type:
- Article
The world's first CRISPR therapy is approved: who will receive it?
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 1, p. 3, doi. 10.1038/d41587-023-00016-6
- By:
- Publication type:
- Article
Can gene editing drive out HIV and hepatitis viruses from inside cells?
- Published in:
- Nature Biotechnology, 2023, v. 41, n. 11, p. 1491, doi. 10.1038/s41587-023-02022-0
- By:
- Publication type:
- Article
Drugs catch a ride through the blood–brain barrier.
- Published in:
- Nature Biotechnology, 2023, v. 41, n. 9, p. 1182, doi. 10.1038/s41587-023-01936-z
- By:
- Publication type:
- Article
Unprecedented blood biomarker enables ALS drug approval.
- Published in:
- Nature Biotechnology, 2023, v. 41, n. 7, p. 886, doi. 10.1038/s41587-023-01862-0
- By:
- Publication type:
- Article
Why gene therapies must go virus-free.
- Published in:
- Nature Biotechnology, 2023, v. 41, n. 6, p. 737, doi. 10.1038/s41587-023-01824-6
- By:
- Publication type:
- Article
Genetic medicines aim straight for the heart.
- Published in:
- Nature Biotechnology, 2023, v. 41, n. 4, p. 435, doi. 10.1038/s41587-023-01745-4
- By:
- Publication type:
- Article
Shoot the messenger: RNA editing is here.
- Published in:
- Nature Biotechnology, 2023, v. 41, n. 3, p. 306, doi. 10.1038/s41587-023-01709-8
- By:
- Publication type:
- Article
Industry appetite for natural killer cells intensifies.
- Published in:
- Nature Biotechnology, 2023, v. 41, n. 2, p. 159, doi. 10.1038/s41587-023-01671-5
- By:
- Publication type:
- Article
For hemophilia and thalassemia, a new era of 'one-and-done' gene therapies has arrived.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 11, p. 1531, doi. 10.1038/s41587-022-01555-0
- By:
- Publication type:
- Article
Repairing the eye.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 10, p. 1419, doi. 10.1038/s41587-022-01506-9
- By:
- Publication type:
- Article
Gene therapy rescues newborns with spinal muscular atrophy.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 8, p. 669, doi. 10.1038/nbt0818-669
- By:
- Publication type:
- Article
mRNA printers kick-start personalized medicines for all.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 8, p. 1160, doi. 10.1038/s41587-022-01430-y
- By:
- Publication type:
- Article
RNA drugs lower lipoprotein(a) and genetically driven cholesterol.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 7, p. 983, doi. 10.1038/s41587-022-01396-x
- By:
- Publication type:
- Article
Topical herpesvirus gene therapy enters final lap.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 6, p. 809, doi. 10.1038/s41587-022-01362-7
- By:
- Publication type:
- Article
COVID-19 vaccine makers chase variant-ready vaccines.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 2, p. 1, doi. 10.1038/d41587-022-00001-5
- By:
- Publication type:
- Article
Off-the-shelf, gene-edited CAR-T cells forge ahead, despite safety scare.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 1, p. 1, doi. 10.1038/d41587-021-00027-1
- By:
- Publication type:
- Article
Publisher Correction: Sickle cell gene therapies approach watershed.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
First COVID-19 DNA vaccine approved, others in hot pursuit.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 12, p. 1479, doi. 10.1038/d41587-021-00023-5
- By:
- Publication type:
- Article
Sickle cell gene therapies approach watershed.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 11, p. 1320, doi. 10.1038/s41587-021-01121-0
- By:
- Publication type:
- Article
Publisher Correction: Oncologists greet Lumakras: the world's first KRAS inhibitor.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Oncologists greet Lumakras: the world's first KRAS inhibitor.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 9, p. 1032, doi. 10.1038/s41587-021-01053-9
- By:
- Publication type:
- Article
CRISPR therapies march into clinic, but genotoxicity concerns linger.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 8, p. 897, doi. 10.1038/d41587-021-00017-3
- By:
- Publication type:
- Article
Publisher Correction: Questions swirl around failures of disease-modifying Huntington's drugs.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Questions swirl around failures of disease-modifying Huntington's drugs.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 6, p. 650, doi. 10.1038/s41587-021-00955-y
- By:
- Publication type:
- Article
COVID-19 testing turns to T cells.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 5, p. 533, doi. 10.1038/s41587-021-00920-9
- By:
- Publication type:
- Article
Innovators target vaccines for variants and shortages in global South.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 4, p. 393, doi. 10.1038/d41587-021-00001-x
- By:
- Publication type:
- Article
Bispecific antibodies poised to deliver wave of cancer therapies.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 3, p. 251, doi. 10.1038/s41587-021-00850-6
- By:
- Publication type:
- Article
Publisher Correction: First small-molecule drug targeting RNA gains momentum.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
First small-molecule drug targeting RNA gains momentum.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 1, p. 6, doi. 10.1038/s41587-020-00788-1
- By:
- Publication type:
- Article
A reprieve from hemophilia A, but for how long?
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 10, p. 1107, doi. 10.1038/s41587-020-0693-y
- By:
- Publication type:
- Article
Massive data initiatives and AI provide testbed for pandemic forecasting.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 9, p. 1010, doi. 10.1038/s41587-020-0671-4
- By:
- Publication type:
- Article
COVID-19 spurs wave of innovative diagnostics.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 7, p. 769, doi. 10.1038/s41587-020-0597-x
- By:
- Publication type:
- Article
Convalescent serum lines up as first-choice treatment for coronavirus.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 6, p. 655, doi. 10.1038/d41587-020-00011-1
- By:
- Publication type:
- Article
Coronavirus and the race to distribute reliable diagnostics.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 4, p. N.PAG, doi. 10.1038/d41587-020-00002-2
- By:
- Publication type:
- Article
Huntington's antisense drug marches into clinic.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 3, p. 251, doi. 10.1038/s41587-020-0452-0
- By:
- Publication type:
- Article
Drugmakers turn sights on scarred lungs.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 2, p. 118, doi. 10.1038/s41587-020-0415-5
- By:
- Publication type:
- Article
Grail of RAS cancer drugs within reach.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 1, p. 6, doi. 10.1038/s41587-019-0382-x
- By:
- Publication type:
- Article
PCSK9-gene-silencing, cholesterol-lowering drug impresses.
- Published in:
- Nature Biotechnology, 2019, v. 37, n. 12, p. 1385, doi. 10.1038/s41587-019-0351-4
- By:
- Publication type:
- Article
Nature Biotechnology's academic spinouts of 2018.
- Published in:
- Nature Biotechnology, 2019, v. 37, n. 6, p. 601, doi. 10.1038/s41587-019-0139-6
- By:
- Publication type:
- Article
Llama-inspired antibody fragment approved for rare blood disorder.
- Published in:
- Nature Biotechnology, 2019, v. 37, n. 4, p. 333, doi. 10.1038/s41587-019-0101-7
- By:
- Publication type:
- Article
Publisher Correction: Death by inflammation: drug makers chase the master controller.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Drug developers switch gears to inhibit STING.
- Published in:
- Nature Biotechnology, 2019, v. 37, n. 3, p. 199, doi. 10.1038/s41587-019-0060-z
- By:
- Publication type:
- Article
Death by inflammation: drug makers chase the master controller.
- Published in:
- Nature Biotechnology, 2019, v. 37, n. 2, p. 111, doi. 10.1038/s41587-019-0023-4
- By:
- Publication type:
- Article
To win at gene therapy, companies pick viruses with production credentials.
- Published in:
- Nature Biotechnology, 2019, v. 37, n. 1, p. 5, doi. 10.1038/nbt0119-5
- By:
- Publication type:
- Article
Wnt is back in drugmakers' sights, but is it druggable?
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 11, p. 1028, doi. 10.1038/nbt1118-1028
- By:
- Publication type:
- Article
Roche splashes $2.4 billion on Foundation Medicine's cancer platform.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 10, p. 779, doi. 10.1038/nbt0918-779
- By:
- Publication type:
- Article